Skip to main content
. 2022 Aug 3;2022(8):CD013829. doi: 10.1002/14651858.CD013829.pub2

Comparison 2. Primary outcome: number of non‐invasive and invasive tests ‐ all time points.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
2.1 Number of invasive tests 4   Risk Ratio (M‐H, Random, 95% CI) Subtotals only
2.1.1 at baseline 3 59222 Risk Ratio (M‐H, Random, 95% CI) 2.90 [2.25, 3.75]
2.1.2 at follow‐up 3 60003 Risk Ratio (M‐H, Random, 95% CI) 2.60 [2.41, 2.80]
2.2 Non‐invasive tests 3   Risk Ratio (M‐H, Random, 95% CI) Subtotals only
2.2.1 at baseline 3 59222 Risk Ratio (M‐H, Random, 95% CI) 3.28 [2.40, 4.48]
2.2.2 at follow‐up 2 55905 Risk Ratio (M‐H, Random, 95% CI) 3.56 [1.81, 7.01]
2.3 Number of invasive test for false positive 4 63323 Risk Ratio (M‐H, Random, 95% CI) 3.84 [3.18, 4.64]
2.3.1 at baseline 1 3318 Risk Ratio (M‐H, Random, 95% CI) 3.09 [1.57, 6.07]
2.3.2 at follow‐up 3 60005 Risk Ratio (M‐H, Random, 95% CI) 3.91 [3.21, 4.76]
2.4 Death postsurgery 2 409 Risk Ratio (M‐H, Random, 95% CI) 0.68 [0.24, 1.94]